• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤ 24 hours) after an acute …

Abstract Purpose of Review The benefit of using antiplatelet monotherapy in acute ischemic
stroke and secondary stroke prevention is well established. In the last few years, several …

Introduction The alterations of gut microbiota have been associated with multiple diseases.
However, the relationship between gut microbiota and adverse outcomes of hyperlipidemic …

Background China is one of the countries with the highest burden of stroke. Implementing
multidimensional management guidelines will help clinicians practise evidence-based care …

Background It remains unclear if intensive antiplatelet and statin treatments begun within 24–
72 hours of cerebral ischaemic events from intracranial or extracranial atherosclerosis is …

Intravenous thrombolysis (IVT) and dual antiplatelet therapy (DAPT) have been widely used
in minor ischemic stroke (MIS) treatment. However, the clinical outcomes and safety of these …

Antiplatelet therapy is the first-line management for noncardioembolic transient ischemic
attack (TIA) and acute ischemic stroke (IS). Herein, we review the safety and efficacy of …

Intensive antiplatelet therapy did not reduce recurrent stroke/transient ischaemic attack (TIA)
events as compared with guideline treatment in the Triple Antiplatelets for Reducing …

Rationale: Early neurological deterioration (END) within 72 h of stroke onset is associated
with poor prognosis. Optimizing hydration might reduce the risk of END. Aims: This study …